Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc

Strong evidence has accumulated on the prognostic value of tumour-associated proteolytic factors in patients afflicted with solid malignant tumours, including advanced ovarian cancer. We evaluated the prognostic impact of the protease urokinase plasminogen activator (uPA) and its inhibitor PAI-1 on...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuhn, W, Schmalfeldt, B, Reuning, U, Pache, L, Berger, U, Ulm, K, Harbeck, N, Späthe, K, Dettmar, P, Höfler, H, Jänicke, F, Schmitt, M, Graeff, H
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362775/
https://www.ncbi.nlm.nih.gov/pubmed/10206287
http://dx.doi.org/10.1038/sj.bjc.6690278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362775/
https://www.ncbi.nlm.nih.gov/pubmed/10206287
http://dx.doi.org/10.1038/sj.bjc.6690278

Ejemplares similares